TITLE

The Role of Myelopoietic Growth Factors in Managing Cancer in the Elderly

AUTHOR(S)
Balducci, L.; Carreca, I.
PUB. DATE
June 2002
SOURCE
Drugs;2002 Supplement 1, Vol. 62 Issue 9, p47
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
More than 50% of all malignancies are diagnosed in patients aged >65 years and most cancer-related deaths occur in this population. Misconceptions about prognosis and treatment contribute to the undertreatment of elderly cancer patients and consequent poor outcomes. Although older patients have been excluded from cancer treatment trials in the past, response rates to chemotherapy in a variety of common cancers in otherwise healthy elderly patients are comparable to those attained in younger patients. Lower functional reserve in many organ systems alters the pharmacokinetics of chemotherapeutic drugs as well as the patient's response to treatment-induced toxicity. Except for myelosuppression and mucositis, otherwise fit elderly cancer patients are not at significantly enhanced risk of toxicity to chemotherapy. Severe neutropenia and related infection are encountered much more frequently during the treatment of elderly as compared with younger cancer patients. These lead to treatment delays, dose reductions and higher hospitalisation rates. Myelopoietic growth factor support reduces myelosuppression and the associated risk of severe infection, thereby allowing delivery of chemotherapy at full dose intensity. Beneficial responses to granulocyte colony-stimulating factor (G-CSF; filgrastim) in elderly patients have been found in aggressive non-Hodgkin's lymphoma with standard cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) therapy and acute myeloid leukaemia (AML) during induction and consolidation chemotherapy. Granulocyte-macrophage colony-stimulating factor (GM-CSF; sargramostim) has been found to reduce myelosuppression in elderly AML patients receiving induction but not consolidation chemotherapy. These prophylactic treatments produce significant cost benefits because of the reduced hospitalisation and antibiotic use associated with neutropenia. To maximise positive outcomes, elderly patients should be included in clinical trials of new cancer agents. Since myelosuppression is the main risk factor for elderly patients undergoing chemotherapy, optimisation of growth factor support and the development of more effective and safer myelopoietic agents may improve success rates and reduce adverse events. Such information will lead to better management of cancer in older patients.
ACCESSION #
7732516

 

Related Articles

  • Contemporary Proton Therapy Systems Adequately Protect Patients from Exposure to Stray Radiation. Newhauser, Wayne D.; Fontenot, Jonas D.; Taddei, Phillip J.; Mirkovic, Dragan; Giebeler, Annelise; Zhang, Rui; Mahajan, Anita; Kornguth, David; Stovall, Marilyn; Yepes, Pablo; Woo, Shiao; Mohan, Radhe // AIP Conference Proceedings;3/15/2009, Vol. 1099 Issue 1, p450 

    Proton beam therapy has provided safe and effective treatments for a variety of adult cancers. In recent years, there has been increasing interest in utilizing proton therapy for pediatric cancers because it allows better sparing of healthy tissues. Minimizing exposures of normal tissues is...

  • CORRECTION.  // Journal of Neurology, Neurosurgery & Psychiatry;Dec2008, Vol. 79 Issue 12, p1416 

    A correction to the article "Misleading conclusions on rt-PA treatment in the very elderly," by P. C. A. Vroomen, M. Uyttenbogaart and G. J. Luijckv is presented.

  • A Perspective on Cellular Immunity in the Elderly. Khanna, Kristen V.; Markham, Richard B. // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p710 

    Examines the importance of recognition of the potential importance of defects in constitutive cellular immunity in the elderly. Immune defects in the elderly; Model for deficient T-cell function; Comparison of constitutive and acquired immunity; Intervention for deficiencies in constitutive...

  • Antibiotic Use in the Elderly: Issues and Nonissues. McCue, Jack D. // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p750 

    Discusses issues on antibiotic use in the elderly. List of available antibiotics; Guidelines for the administration of antibiotics; Concern on the duration of therapy.

  • Nonpharmacologic steps to improve sleep in older adults. Huffman, Grace Brooke // American Family Physician;11/15/1998, Vol. 58 Issue 8, p1842 

    Discusses the study conducted to determine the feasibility and effectivity of the nonpharmacologic approach in treating sleep disturbances in elderly hospitalized patients. Details on the nonpharmacologic sleep protocol; Methods used in the study; Concluding remarks.

  • Correlates of Use of Alternative Medicine by the Elderly in an Urban Population. Cherniack, E. Paul; Senzel, Richard S.; Pan, Cynthia X. // Journal of Alternative & Complementary Medicine;Jun2001, Vol. 7 Issue 3, p277 

    Objective: To investigate the prevalence and predictors of use of complementary and alternative medicine (CAM) by the elderly. Design: Cross-sectional survey examining patterns of use of complementary therapies in two urban multiethnic populations of older adults. Setting and Subjects: A...

  • Metastatic adenocarcinoma in a 70-year-old. Caso Jr., George R. // Cortlandt Forum;5/25/96, Vol. 9 Issue 5, p118 

    Ask advice on the treatment of a 70-year-old patient with metastatic adenocarcinoma. Suggestion for palliative radiation therapy.

  • Enough is enough! Kanoff, Hymen // Cortlandt Forum;6/25/96, Vol. 9 Issue 6, p53 

    Relates the experience of Dr. Hymen Kanoff, a general practitioner from Philadelphia, Pennsylvania, about an unusual case of an old woman who refused any treatment for her syncope brought about by colonic bleeding. Patient's wish for the suspension of all treatment; Care and attention given by...

  • Building bone, relieving pain. O'Connor, Patrick G.; Berkowitz, Henry D.; Cohn, Peter F.; Gorman, B. David; Lief, Philip D.; Mishell Jr., Daniel R.; Nichols, Gwen L.; Rigsby, Michael O.; Ryan, Michael E. // Cortlandt Forum;12/20/97, Vol. 10 Issue 12, p102 

    Presents information on the starting dose of alendronate needed for a 77-year-old woman with a fractured spine and kyphoscoliosis secondary to osteoporosis.

  • Aging population sparks drug sales and research. D.R.G. // Caribbean Business;11/4/1999, Vol. 27 Issue 43, p44 

    Forecasts the growth of pharmaceutical companies as majority of American elders are using drugs to treat diseases linked to aging. Projected increase in prescription sales by 2005, according to the National Association of Chain Drug Stores; Worldwide value of diabetes medication market;...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics